← FDA DRUG APPROVALS

FDA NDA · NDA006904

TERFONYL

Sponsor: BRISTOL MYERS SQUIBB

APPLICATION
NDA006904
TYPE
NDA
ROUTE
ORAL
DOSAGE FORM
SUSPENSION, TABLET
MARKETING STATUS
Discontinued

Products

TERFONYLDiscontinued
TRISULFAPYRIMIDINES (SULFADIAZINE 167MG/5ML, SULFAMERAZINE 167MG/5ML, SULFAMETHAZINE) 167MG/5ML · SUSPENSION · ORAL
TERFONYLDiscontinued
TRISULFAPYRIMIDINES (SULFADIAZINE 167MG, SULFAMERAZINE 167MG, SULFAMETHAZINE) 167MG · TABLET · ORAL
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →